LDC-4297 | Interleukin Related interleukin-related.com

Product Name :
LDC-4297

Search keywords :
LDC4297

drugId :
null

Target Vo:
Cyclin-dependent kinase 7

Target Vo Short Name :
CDK7

Moa_Name:
Cyclin-dependent kinase 7 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Lead Discovery Center

Active Company_Name :
Lead Discovery Center

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ctip2 Antibody
Caspase-9 Antibody
Toll-Like Receptor 3 Antibody (YA659): Toll-Like Receptor 3 Antibody (YA659) is a non-conjugated and Mouse origined monoclonal antibody about 104 kDa, targeting to Toll-Like Receptor 3 (2F10). It can be used for WB assays with tag free, in the background of Transfected.

Author: Interleukin Related

Related Posts